Glycyrrhiza glabra

Alternative Medicine Review

Volumn 10, Issue 3, 2005, Pages 230-237

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; AMINO ACID; ASPARTATE AMINOTRANSFERASE; CARBENOXOLONE; CARBOHYDRATE; CHALCONE; CIMETIDINE; DEGLYCYRRHIZINATED LIQUORICE; FLAVONOID; GLABRENE; GLABRIDIN; GLUCURONIC ACID; GLYCYRRHETINIC ACID; GLYCYRRHIZA EXTRACT; GLYCYRRHIZIC ACID; HISPAGLABRIDIN A; HISPAGLABRIDIN B; INTERFERON; ISOFLAVONE DERIVATIVE; LIVER ENZYME; MINERAL; PECTIN; PHOSPHOLIPASE A2; POLYSACCHARIDE; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE; RIBAVIRIN; SAPONIN; STEROID 5BETA REDUCTASE; STRONGER NEO MINOPHAGEN C; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIVIRAL ACTIVITY; CANCER INHIBITION; CHLOASMA; CHRONIC HEPATITIS; CLINICAL TRIAL; DRUG EFFICACY; DRUG INDICATION; DRUG MECHANISM; DRUG POTENCY; DUODENUM ULCER; DYSPHAGIA; ECZEMA; EDEMA; ENTEROHEPATIC CIRCULATION; EROSIVE GASTRITIS; GLYCYRRHIZA GLABRA; HEART ARRHYTHMIA; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HEPATITIS; HERPES ZOSTER; HUMAN; HYPERALDOSTERONISM; HYPERTENSION; HYPOKALEMIA; INFLAMMATION; LICHEN PLANUS; LIVER CIRRHOSIS; LIVER PROTECTION; METABOLIC ACIDOSIS; NONHUMAN; ORTHOSTATIC HYPOTENSION; PAIN; PERITONITIS; PLASMA RENIN ACTIVITY; RASH; REVIEW; SODIUM RETENTION; ULCER; ULCER HEALING; VIRUS INFECTION; ARTICLE; CHEMISTRY; GLYCYRRHIZA; PHYTOTHERAPY;

GLYCYRRHIZA; PHYTOTHERAPY;

EID: 25644435756     PISSN: 10895159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (69)

1. Olukoga A, Donaldson D. Historical perspectives on health. The history of liquorice: the plant, its extract, cultivation, and commercialisation and etymology. J R Soc Health 1998;118:300-304.
2. Obolentseva GV, Litvinenko VI, Ammosov AS, et al. Pharmacological and therapeutic properties of licorice preparations (a review). Pharm Chem J 1999;33:24-31.
3. Yamamura Y, Kawakami J, Santa T, et al. Pharmacokinetic profile of glycerrhizin in healthy volunteers by a new high-performance liquid chromatographic method. J Pharm Sci 1992;81:1042-1046.
4. Vaya J, Belinky PA, Aviram M. Antioxidant constituents from licorice roots: isolation, structure elucidation and antioxidative capacity toward LDL oxidation. Free Radic Biol Med 1997;23:302-313.
5. Tamir S, Eizenberg M, Somjen D, et al. Estrogen-like activity of glabrene and other constituents isolated from licorice root. J Steroid Biochem Mol Biol 2001;78:291-298.
6. Hattori M, Sakamoto T, Yamagishi T, et al. Metabolism of glycyrrhizin by human intestinal flora. II. Isolation and characterization of human intestinal bacteria capable of metabolizing glycyrrhizin and related compounds. Chem Pharm Bull (Tokyo) 1985;33:210-217.
7. Akao T, Akao T, Hattori M, et al. Hydrolysis of glycyrrhizin to 18 beta-glycyrrhetyl monoglucuronide by lysosomal beta-D-glucuronidase of animal livers. Biochem Pharmacol 1991;41:1025-1029.
8. Ploeger B, Mensinga T, Sips A, et al. The pharmacokinetics of glycyrrhizic acid evaluated by physiologically based pharmacokinetic modeling. Drug Metab Rev 2001;33:125-147.
9. Crance JM, Biziagos E, Passagot J, et al. Inhibition of hepatitis A virus replication in vitro by antiviral compounds. J Med Virol 1990;31:155-160.
10. Van Rossum TG, Vulto AG, Hop WC, et al. Intravenous glycyrrhizin for the treatment of chronic hepatitis C: a double-blind, randomized, placebo-controlled phase I/II trial. J Gastroenterol Hepatol 1999;14:1093-1099.
11. Su XS, Chen HM, Wang LH, et al. Clinical and laboratory observation on the effect of glycyrrhizin in acute and chronic viral hepatitis. J Tradit Chin Med 1984;4:127-132.
12. Baba M, Shigeta S. Antiviral activity of glycyrrhizin against Varicella-zoster virus in vitro. Antiviral Res 1987;7:99-107.
13. Hattori T, Ikematsu S, Koito A, et al. Preliminary evidence for inhibitory effect of glycyrrhizin on HIV replication in patients with AIDS. Antiviral Res 1989;11:255-261.
14. Ito M, Sato A, Hirabayashi K, et al. Mechanism of inhibitory effect of glycyrrhizin on replication of human immunodeficiency virus (HIV). Antiviral Res 1988;10:289-298.
15. Pompei R, Flore O, Marccialis MA, et al. Glycyrrhizic acid inhibits virus growth and inactivates virus particles. Nature 1979;281:689-690.
16. Partridge M, Poswillo DE. Topical carbenoxolone sodium in the management of herpes simplex infection. Br J Oral Maxillofac Surg 1984;22:138-145.
17. Numazaki K, Umetsu M, Chiba S. Effect of glycyrrhizin in children with liver dysfunction associated with cytomegalovirus infection. Tohoku J Exp Med 1994;172:147-153.
18. Armanini D, Karbowiak I, Funder JW. Affinity of liquorice derivatives for mineralocorticoid and glucocorticoid receptors. Clin Endocrinol (Oxf) 1983;19:609-612.
19. Okimasu E, Moromizato Y, Watanabe S, et al. Inhibition of phospholipase A2 and platelet aggregation by glycyrrhizin, an antiinflammation drug. Acta Med Okayama 1983;37:385-391.
20. Ohuchi K, Tsurufuji A. A study of the anti-inflammatory mechanism of glycyrrhizin. Mino Med Rev 1982;27:188-193.
21. Akamatsu H, Komura J, Asada Y, Niwa Y. Mechanism of anti-inflammatory action of glycyrrhizin: effect on neutrophil functions including reactive oxygen species generation. Planta Med 1991;57:119-121.
22. Wang ZY, Nixon DW. Licorice and cancer. Nutr Cancer 2001;39:1-11.
23. Haraguchi H, Yoshida N, Ishikawa H, et al. Protection of mitochondrial functions against oxidative stresses by isoflavans from Glycyrrhiza glabra. J Pharm Pharmacol 2000;52:219-223.
24. Nagai T, Egashira T, Yamanaka Y, Kohno M. The protective effect of glycyrrhizin against injury of the liver caused by ischemia-reperfusion. Arch Environ Contam Toxicol 1991;20:432-436.
25. Van Rossum TG, Vulto AG, Hop WC, Schalm SW. Glycyrrhizin-induced reduction of ALT in European patients with chronic hepatitis C. Am J Gastroenterol 2001;96:2432-2437.
26. Tamir S, Eizenberg M, Somjen D, et al. Estrogenic and antiproliferative properties of glabridin from licorice in human breast cancer cells. Cancer Res 2000;60:5704-5709.
27. Shiota G, Harada K, Ishida M, et al. Inhibition of hepatocellular carcinoma by glycyrrhizin in diethylnitrosamine-treated mice. Carcinogenesis 1999;20:59-63.
28. Nishino H, Kitagawa K, Iwashima A. Antitumor-promoting activity of glycyrrhetic acid in mouse skin tumor formation induced by 7,12 dimethylbenz[a]anthracene plus teleocidin. Carcinogenesis 1984;5:1529-1530.
29. Liu W, Kato M, Akhand A, et al. The herbal medicine Sho-saiko-to inhibits the growth of malignant melanoma cells by up-regulating Fas-mediated apoptosis and arresting cell cycle through down regulation of cyclin dependent kinases. Int J Oncol 1998;12;1321-1326.
30. Van Marle J, Aarsen PN, Lind A, et al. Deglycyrrhizinised liquorice (DGL) and the renewal of rat stomach epithelium. Eur J Pharmacol 1981;72:219-225.
31. Goso Y, Ogata Y, Ishihara K, Hotta K. Effects of traditional herbal medicine on gastric mucin against ethanol-induced gastric injury in rats. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol 1996;113:17-21.
32. Tsubota A, Kumada H, Arase Y, et al. Combined ursodeoxycholic acid and glycyrrhizin therapy for chronic hepatitis C virus infection: a randomized controlled trial in 170 patients. Eur J Gastroenterol Hepatol 1999;11:1077-1083.
33. Iino S, Tango T, Matsushima T, et al. Therapeutic effects of stronger neo-minophagen C at different doses on chronic hepatitis and liver cirrhosis. Hepatol Res 2001;19:31-40.
34. Da Nagao Y, Sata M, Suzuki H, et al. Effectiveness of glycyrrhizin for oral lichen planus in patients with chronic HCV infection. J Gastroenterol 1996;31:691-695.
35. Hirabayashi K, Iwata S, Matsumoto H, et al. Antiviral activities of glycyrrhizin and its modified compounds against human immunodeficiency virus type 1 (HIV-1) and Herpes simplex virus type 1 (HSV-1) in vitro. Chem Pharm Bull (Tokyo) 1991;39:112-115.
36. Pompei R, Pani A, Flore O, et al. Antiviral activity of glycyrrhizic acid. Experientia 1980;36:304.
37. Aikawa Y, Yoshiike T, Ogawa H. Effect of glycyrrhizin on pain and HLA-DR antigen expression on CD8-positive cells in peripheral blood of herpes zoster patients in comparison with other antiviral agents. Skin Pharmacol 1990;3:268-271.
38. Numazaki K, Chiba S. Natural course and trial of treatment for infantile liver dysfunction associated with cytomegalovirus infections. In Vivo 1993;7:477-480.
39. Numazaki K. Glycyrrhizin therapy for liver dysfunction associated with cytomegalovirus infection in immunocompetent children. Antimicrobics Infect Dis Newsl 1998;17:70-71.
40. Arase Y, Ikeda K, Murashima N, et al. The long term efficacy of glycyrrhizin in chronic hepatitis C patients. Cancer 1997;79:1494-1500.
41. Kumada H. Long-term treatment of chronic hepatitis C with glycyrrhizin [Stronger Neo-Minophagen C (SNMC)] for preventing liver cirrhosis and hepatocellular carcinoma. Oncology 2002;62:94-100.
42. Poswillo D, Partridge M. Management of recurrent aphthous ulcers. Br Dent J 1984;157:55-57.
43. Das SK, Das V, Gulati AK, Singh VP. Deglycyrrhizinated liquorice in apthous ulcers. J Assoc Physicians India 1989;37:647.
44. Loginov AS, Speransky MD, Speranskaya IE, et al. The effectiveness of carbenoxolone in the treatment of gastro-duodenal ulcer patients. Scand J Gastroenterol Suppl 1980;65:85-91.
45. Shibata S. A drug over the millennia: pharmacognosy, chemistry, and pharmacology of licorice. Yakugaku Zasshi 2000;120:849-862.
46. Morgan AG, McAdam WA, Pacsoo C, Darnborough A. Comparison between cimetidine and Caved-S in the treatment of gastric ulceration, and subsequent maintenance therapy. Gut 1982;23:545-551.
47. Morgan AG, Pacsoo C, McAdam WA. Maintenance therapy, a two year comparison between Caved-S and cimetidine treatment in the prevention of symptomatic gastric ulcer recurrence. Gut 1985;26:599-602.
48. Turpie AG, Runcie J, Thomson TJ. Clinical trial of deglycyrrhizinized liquorice in gastric ulcer. Gut 1969;10:299-302.
49. Glick L. Deglycyrrhizinated liquorice for peptic ulcer. Lancet 1982;2:817.
50. Peterson WL. Helicobacter pylori and peptic ulcer disease. N Engl J Med 1991;324:1043-1048.
51. Parsonnet J. Helicobacter pylori in the stomach - a paradox unmasked. N Engl J Med 1996;335:278-280.
52. Fukai T, Marumo A, Kaitou K, et al. Anti-Helicobacter pylori flavonoids from licorice extract. Life Sci 2002;71:1449-1463.
53. Tewari SN, Wilson AK. Deglycyrrhizinated liquorice in duodenal ulcer. Practitioner 1973;210:820-823.
54. Kassir ZA. Endoscopic controlled trial of four drug regimens in the treatment of chronic duodenal ulceration. Ir Med J 1985;78:153-156.
55. Armanini D, De Palo CB, Mattarello MJ, et al. Effect of licorice on the reduction of body fat mass in healthy subjects. J Endocrinol Invest 2003;26:646-650.
56. Armanini D, Mattarello MJ, Fiore C, et al. Licorice reduces serum testosterone in healthy women. Steroids 2004;69:763-766.
57. Evans FQ. The rational use of glycyrrhetinic acid in dermatology. Br J Clin Pract 1958;12:269-274.
58. Amer M, Metwalli M. Topical liquiritin improves melasma. Int J Dermatol 2000;39:299-301.
59. Takeda H, Ohta K, Niki H, et al. Eosinophilic peritonitis responding to treatment with glycyrrhizin. Tokai J Exp Clin Med 1991;16:183-186.
60. Basso A, Dalla Paola L, Erle G, et al. Licorice ameliorates postural hypotension caused by diabetic autonomic neuropathy. Diabetes Care 1994;17:1356.
61. Kolarski V, Petrova-Shopova K, Vasileva E, et al. Erosive gastritis and gastroduodenitis - clinical, diagnostic and therapeutic studies. Vutr Boles 1987;26:56-59. [Article in Bulgarian]
62. Chen M, Theander TG, Christensen SB, et al. Licochalcone A, a new anti-malarial agent, inhibits in vitro growth of the human malaria parasite Plasmodium falciparum and protects mice from P. yoelii infection. Antimicrob Agents Chemother 1994;38:1470-1475.
63. Christensen SB, Ming C, Anderson L, et al. An antileishmanial chalcone from Chinese licorice roots. Planta Med 1994;60:121-123.
64. Parle M, Dhingra D, Kulkarni SK. Memory-strengthening activity of Glycyrrhiza glabra in exteroceptive and interoceptive behavioral models. J Med Food 2004;7:462-466.
65. Hoes AW, Grobbee DE, Peet TM, Lubsen J. Do non-potassium-sparing diuretics increase the risk of sudden cardiac death in hypertensive patients? Recent evidence. Drugs 1994;47:711-733.
66. Clyburn EB, DiPette DJ. Hypertension induced by drugs and other substances. Semin Nephrol 1995;15:72-86.
67. Olukoga A, Donaldson D. Liquorice and its health implications. J R Soc Health 2000;120:83-89.
68. Stormer FC, Reistad R, Alexander J. Glycyrrhizic acid in liquorice - evaluation of health hazard. Food Chem Toxicol 1993;31:303-312.
69. Walker BR, Edwards CR. Licorice-induced hypertension and syndromes of apparent mineralocorticoid excess. Endocrinol Metab Clin North Am 1994;23:359-377.